CRNX Covered Call Strategy
CRNX (Crinetics Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
CRNX (Crinetics Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.87B, a beta of 0.24 versus the broader market, a 52-week range of 25.83-57.99, average daily share volume of 1.2M, a public-listing history dating back to 2018, approximately 437 full-time employees. These structural characteristics shape how CRNX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.24 indicates CRNX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on CRNX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current CRNX snapshot
As of June 30, 2026, spot at $37.29, ATM IV 459.20%, IV rank 93.93%, expected move 131.65%. The covered call on CRNX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this covered call structure on CRNX specifically: CRNX IV at 459.20% is rich versus its 1-year range, which favors premium-selling structures like a CRNX covered call, with a market-implied 1-standard-deviation move of approximately 131.65% (roughly $49.09 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRNX expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRNX should anchor to the underlying notional of $37.29 per share and to the trader's directional view on CRNX stock.
CRNX covered call setup
The CRNX covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRNX near $37.29, the first option leg uses a $39.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRNX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRNX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $37.29 | long |
| Sell 1 | Call | $39.00 | $0.38 |
CRNX covered call risk and reward
- Net Premium / Debit
- -$3,691.00
- Max Profit (per contract)
- $209.00
- Max Loss (per contract)
- -$3,690.00
- Breakeven(s)
- $36.91
- Risk / Reward Ratio
- 0.057
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
CRNX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on CRNX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$3,690.00 |
| $8.25 | -77.9% | -$2,865.61 |
| $16.50 | -55.8% | -$2,041.22 |
| $24.74 | -33.7% | -$1,216.82 |
| $32.99 | -11.5% | -$392.43 |
| $41.23 | +10.6% | +$209.00 |
| $49.47 | +32.7% | +$209.00 |
| $57.72 | +54.8% | +$209.00 |
| $65.96 | +76.9% | +$209.00 |
| $74.21 | +99.0% | +$209.00 |
When traders use covered call on CRNX
Covered calls on CRNX are an income strategy run on existing CRNX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
CRNX thesis for this covered call
The market-implied 1-standard-deviation range for CRNX extends from approximately $-11.80 on the downside to $86.38 on the upside. A CRNX covered call collects premium on an existing long CRNX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether CRNX will breach that level within the expiration window. Current CRNX IV rank near 93.93% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on CRNX at 459.20%. As a Healthcare name, CRNX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRNX-specific events.
CRNX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRNX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRNX alongside the broader basket even when CRNX-specific fundamentals are unchanged. Short-premium structures like a covered call on CRNX carry tail risk when realized volatility exceeds the implied move; review historical CRNX earnings reactions and macro stress periods before sizing. Always rebuild the position from current CRNX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on CRNX?
- A covered call on CRNX is the covered call strategy applied to CRNX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With CRNX stock trading near $37.29, the strikes shown on this page are snapped to the nearest listed CRNX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CRNX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the CRNX covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 459.20%), the computed maximum profit is $209.00 per contract and the computed maximum loss is -$3,690.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CRNX covered call?
- The breakeven for the CRNX covered call priced on this page is roughly $36.91 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRNX market-implied 1-standard-deviation expected move is approximately 131.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on CRNX?
- Covered calls on CRNX are an income strategy run on existing CRNX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current CRNX implied volatility affect this covered call?
- CRNX ATM IV is at 459.20% with IV rank near 93.93%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.